Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 499 entries
View as:

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Phase: N/A Priority: Normal
NCT ID: NCT00891878 Org: User:
Start: 08/31/09 End: 01/31/13 Due: 01/31/14

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003854 Org: User:
Start: 04/30/99 End: 07/31/11 Due: 07/31/12

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01167725 Org: User:
Start: 08/31/10 End: 01/31/12 Due: 01/31/13

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00651261 Org: User:
Start: 04/30/08 End: - Due: -

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00053196 Org: User:
Start: 12/31/02 End: 08/31/10 Due: 08/31/11

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Phase: N/A Priority: Normal
NCT ID: NCT00006483 Org: User:
Start: 10/31/00 End: 01/31/13 Due: 01/31/14

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00068328 Org: User:
Start: 08/31/03 End: 12/31/16 Due: 12/31/17

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Phase: N/A Priority: Normal
NCT ID: NCT00968214 Org: User:
Start: 09/30/08 End: 09/30/18 Due: 09/30/19

Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00005820 Org: User:
Start: 05/31/00 End: 09/30/06 Due: 09/30/07

Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00454194 Org: User:
Start: 09/30/07 End: 05/31/13 Due: 05/31/14

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003546 Org: User:
Start: 09/30/98 End: 01/31/06 Due: 01/31/07

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00540969 Org: User:
Start: 02/29/08 End: 01/31/10 Due: 01/31/11

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT02856581 Org: User:
Start: 09/29/17 End: 04/15/22 Due: 04/15/23

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Phase: N/A Priority: Normal
NCT ID: NCT00376597 Org: User:
Start: 06/30/06 End: 06/15/17 Due: 06/15/18

Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00316862 Org: User:
Start: 02/28/06 End: 10/15/14 Due: 10/15/15

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Phase: N/A Priority: Normal
NCT ID: NCT00081224 Org: User:
Start: 12/31/04 End: 11/30/10 Due: 11/30/11

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03087708 Org: User:
Start: 03/23/18 End: 04/01/23 Due: 04/01/24

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00017186 Org: User:
Start: 07/31/01 End: 05/31/08 Due: 05/31/09

Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01644799 Org: User:
Start: 07/31/13 End: 05/31/17 Due: 05/31/18

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00056030 Org: User:
Start: 12/31/04 End: - Due: -

Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00003901 Org: User:
Start: 07/31/99 End: 10/31/11 Due: 10/31/12

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00621686 Org: User:
Start: 09/30/08 End: 02/19/14 Due: 02/19/15

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00867321 Org: User:
Start: 04/30/09 End: 05/31/13 Due: 05/31/14

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00343382 Org: User:
Start: 12/31/06 End: 12/31/12 Due: 12/31/13

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00048971 Org: User:
Start: 04/30/02 End: 11/30/06 Due: 11/30/07